Therefore, we investigated pERK immunolabeling in WT and Spry2/4+/− mice 3 days after the initial status epilepticus and in the subchronic stage of progressing neuronal damage (21 days after KA injection). The gene discussed is EIF2AK3; the disease is status epilepticus.